A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications ...

Results reveal that weight loss has significant effects on cellular processes that are known to affect metabolic health and ...

Weight loss jabs will not be enough to make “lasting progress” on tackling the obesity epidemic, leading medics have said.

A GLP-1/glucagon dual agonist conferred weight loss of up to 12.55% at 32 weeks for adults with overweight or obesity, ...

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

Weight loss injections will not be enough to make “lasting progress” in tackling the obesity epidemic, leading medical experts have warned.

The researchers found health perks directly linked with weight loss through blood test results, including increases in HDL ...

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...

Research shows morning workouts may be optimal for weight loss and mental health, though experts stress that quality sleep ...

Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs ...

Losing excess weight has “hidden benefits” and helps clear out damaged and ageing cells, scientists have discovered. They ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...